Research Solutions, Inc. (RSSS)
NASDAQ: RSSS · Real-Time Price · USD
2.240
+0.040 (1.82%)
Jun 23, 2026, 12:23 PM EDT - Market open
Research Solutions Revenue
Research Solutions had revenue of $12.12M in the quarter ending March 31, 2026, a decrease of -4.26%. This brings the company's revenue in the last twelve months to $48.66M, down -0.18% year-over-year. In the fiscal year ending June 30, 2025, Research Solutions had annual revenue of $49.06M with 9.94% growth.
Revenue (ttm)
$48.66M
Revenue Growth
-0.18%
P/S Ratio
1.48
Revenue / Employee
$357,826
Employees
136
Market Cap
72.56M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2025 | 49.06M | 4.43M | 9.94% |
| Jun 30, 2024 | 44.62M | 6.92M | 18.35% |
| Jun 30, 2023 | 37.70M | 4.77M | 14.48% |
| Jun 30, 2022 | 32.93M | 1.18M | 3.71% |
| Jun 30, 2021 | 31.76M | 697.60K | 2.25% |
| Jun 30, 2020 | 31.06M | 2.26M | 7.87% |
| Jun 30, 2019 | 28.79M | 775.50K | 2.77% |
| Jun 30, 2018 | 28.02M | 2.27M | 8.82% |
| Jun 30, 2017 | 25.75M | 1.66M | 6.87% |
| Jun 30, 2016 | 24.09M | -7.81M | -24.48% |
| Jun 30, 2015 | 31.90M | 3.42M | 12.00% |
| Jun 30, 2014 | 28.48M | -17.02M | -37.40% |
| Jun 30, 2013 | 45.50M | 2.68M | 6.26% |
| Jun 30, 2012 | 42.82M | 9.32M | 27.81% |
| Jun 30, 2011 | 33.50M | 8.56M | 34.35% |
| Jun 30, 2010 | 24.94M | 10.28M | 70.17% |
| Jun 30, 2009 | 14.65M | 2.44M | 20.01% |
| Jun 30, 2008 | 12.21M | 8.36M | 217.08% |
| Jun 30, 2007 | 3.85M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Domo, Inc. | 318.15M |
| Lucas GC | 149.02M |
| SoundThinking | 99.96M |
| NetSol Technologies | 72.06M |
| AudioEye | 41.13M |
| Health In Tech | 34.08M |
| Intellicheck | 23.30M |
| Rank One Computing | 16.35M |
RSSS News
- 12 days ago - Research Solutions Transcript: 16th Annual East Coast IDEAS Conference - Transcripts
- 14 days ago - Element Biosciences Announces Upsized Series E to Accelerate Global Growth Across Ecosystem of Genomic, Multiomic, and Clinical Research Solutions - Business Wire
- 19 days ago - Research Solutions to Present and Host 1x1 Investor Meetings at the 16th Annual East Coast IDEAS Investor Conference on June 10th in New York, NY - PRNewsWire
- 5 weeks ago - Research Solutions price target lowered to $4 from $5 at Lake Street - TheFly
- 5 weeks ago - Research Solutions price target lowered to $3.50 from $5 at Roth Capital - TheFly
- 5 weeks ago - Research Solutions price target lowered to $4 from $5 at Maxim - TheFly
- 5 weeks ago - Research Solutions reports Q3 EPS 3c, consensus 4c - TheFly
- 5 weeks ago - Research Solutions Earnings Call Transcript: Q3 2026 - Transcripts